| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/19/2001 | WO2001027270A1 Gene ys68 concerning early hematopoiesis |
| 04/19/2001 | WO2001027269A2 Vip54 protein and related materials |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027260A1 Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same |
| 04/19/2001 | WO2001027255A2 Nucleic acid coding for a ctage gene family, use and production thereof |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027246A1 Novel human potassium channel subunit |
| 04/19/2001 | WO2001027244A1 Body member with adjustable stiffness and frequency |
| 04/19/2001 | WO2001027243A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 04/19/2001 | WO2001027157A1 A biologically active complex of nr6 and cardiotrophin-like-cytokine |
| 04/19/2001 | WO2001027156A1 Interleukin-2 like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027155A1 Human sbgfgf-10a_del23 |
| 04/19/2001 | WO2001027154A2 Membrane translocating peptide drug delivery system |
| 04/19/2001 | WO2001027153A1 A murine seven-transmembrane receptor, mus musculus mhneaa81 |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027151A1 A new polypeptide-human zinc finger protein kruppel family member zfp-52 and the polynucleotide encoding it |
| 04/19/2001 | WO2001027150A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027148A1 A novel polypeptide-homo glutamine(q)-rich factor 56 and polynucleotide encoding said polypeptide |
| 04/19/2001 | WO2001027147A1 A novel molecule |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027144A2 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001027137A2 Rattus norvegicus (edg3) |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026675A1 FcηRIA |
| 04/19/2001 | WO2001026643A1 Inhibition of tumorigenic properties of melanoma cells |
| 04/19/2001 | WO2001026608A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 04/19/2001 | WO2001026607A2 Smdf and ggf neuregulin splice variant isoforms and uses thereof |
| 04/19/2001 | WO2001026459A2 Flowering time modification |
| 04/19/2001 | WO2001026455A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/19/2001 | WO2001026453A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | WO2001019846A8 Transgenically produced fusion proteins |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | WO2001000807A8 MUTATED Nurr1 GENE |
| 04/19/2001 | WO2000078986B1 Regulation system of expression using nuclear ppar receptors |
| 04/19/2001 | WO2000078329A3 The use of the protein uk 114 for inhibiting organ transplant rejection |
| 04/19/2001 | WO2000077239A3 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 04/19/2001 | WO2000076309A3 Non-human transgenic animals deficient in gas6 function and their use |
| 04/19/2001 | WO2000070665A3 Long lasting anti-angiogenic peptides |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000063357A8 Methods and compositions for modulating ciliary neurotrophic factor activity |
| 04/19/2001 | WO2000054573A8 Geminivirus resistant transgenic plants |
| 04/19/2001 | WO2000053753A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/19/2001 | WO2000052039A3 Lectomedin materials and methods |
| 04/19/2001 | WO2000034304A9 Eosinophil-specific expression of transgenes |
| 04/19/2001 | WO2000032047A9 Plasmid maintenance system for antigen delivery |
| 04/19/2001 | WO2000030437A8 Transgenic animals |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000029444A9 Generation of antibodies using polynucleotide vaccination in avian species |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000005373A9 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 04/19/2001 | WO1999051188A3 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 04/19/2001 | DE19947290A1 Verfahren zur Herstellung proteinöser Substanzen A process for preparing proteinaceous substances |
| 04/19/2001 | DE10039844A1 New vector useful in the treatment of malignant disease and other hyperplasia |
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387626A1 Viral particles with exogenous internal epitopes |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387479A1 Human ldl receptor family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387355A1 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387237A1 Novel human potassium channel subunit |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387188A1 Vip54 protein and related materials |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/19/2001 | CA2386177A1 Oculomedin and glaucoma |
| 04/19/2001 | CA2386170A1 Flowering time modification |
| 04/19/2001 | CA2385907A1 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385172A1 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | CA2385154A1 Atp-binding cassette transporter (abc1) modified transgenic mice |
| 04/19/2001 | CA2385134A1 Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | CA2383642A1 Anthozoa derived chromophores/fluorophores and methods for using the same |
| 04/19/2001 | CA2382741A1 Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092775A1 Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 04/18/2001 | EP1092774A2 Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof |
| 04/18/2001 | EP1092773A2 Polypeptide and uses thereof |
| 04/18/2001 | EP1092772A1 Antibody against lar phosphatase subunit |
| 04/18/2001 | EP1092771A2 Tetracycline-regulated transcriptional modulators |